Share
Market Research Report

IN VIVO GENE EDITING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Editing TechnologyCRISPR-Cas Systems · Base Editing · Prime Editing · Zinc Finger Nucleases (ZFNs) · TALENs · Others (including specialized engineered nucleases)
  • By Delivery MethodLipid Nanoparticles (LNPs) · Viral Vectors · Other Nonviral Delivery Systems
  • By Therapeutic ApplicationGenetic and Rare Diseases · Cardiovascular and Metabolic Disorders · Infectious Diseases · Oncology · Others
  • By Target TissueLiver · Hematopoietic Stem Cells and Blood-Forming Tissues · Eye · Muscle · Central Nervous System · Others
  • By End UserPharmaceutical and Biotechnology Companies · Academic and Research Institutes · Contract Research and Development Organizations · Hospitals and Clinical Research Centers · Others
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East · and Africa
  • Published In16 Nov 2026
  • Report CodeCMI10409
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Editing Technology
      • Market Snapshot, By Delivery Method
      • Market Snapshot, By Therapeutic Application
      • Market Snapshot, By Target Tissue
      • Market Snapshot, By End User
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Product Approval
    • Collaboration/Merge/Acquisition
    • Regulatory Landscape
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Epidemiology
    • Robust Pipeline Analysis
  4. Global In Vivo Gene Editing Market, By Editing Technology, 2021 – 2033, (USD Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • CRISPR-Cas Systems
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Base Editing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Prime Editing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Zinc Finger Nucleases (ZFNs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • TALENs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Others (including specialized engineered nucleases)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  5. Global In Vivo Gene Editing Market, By Delivery Method, 2021 – 2033, (USD Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Lipid Nanoparticles (LNPs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Viral Vectors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Other Nonviral Delivery Systems
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  6. Global In Vivo Gene Editing Market, By Therapeutic Application, 2021 – 2033, (USD Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Genetic and Rare Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Cardiovascular and Metabolic Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Infectious Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  7. Global In Vivo Gene Editing Market, By Target Tissue, 2021 – 2033, (USD Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Liver
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Hematopoietic Stem Cells and Blood-Forming Tissues
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Eye
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Muscle
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Central Nervous System
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  8. Global In Vivo Gene Editing Market, By End User, 2021 – 2033, (USD Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Pharmaceutical and Biotechnology Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Academic and Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Contract Research and Development Organizations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Hospitals and Clinical Research Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  9. Global In Vivo Gene Editing Market, By Region, 2021 – 2033, (USD Billion)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
        • North Africa
        • Central Africa
        • South Africa
  10. Competitive Landscape

    • Heat Map Analysis
    • Market Share Analysis
    • Company Profile
      • Intellia Therapeutics
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Beam Therapeutics
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Editas Medicine
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Precision BioSciences
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Metagenomi Therapeutics
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Cellectis
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • YolTech Therapeutics
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • GenEditBio
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Tessera Therapeutics
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • C4U Corporation
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Eli Lilly and Company
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Regeneron Pharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
    • Analyst Views
  11. Section

    • References
    • Research Methodology
    • About Us